Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. Amazon Location Service.

Clinical trial site

Vanderbilt University Medical Center

Vanderbilt University Medical Center in Nashville, Tennessee, United States is listed as a site for 2,143 registered clinical trials, 607 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 2,143
Ongoing 607

This page covers the site record Vanderbilt University Medical Center in Nashville, Tennessee, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Vanderbilt University Medical Center, also sponsors trials.

Get the Vanderbilt University Medical Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 2,143 trials counted.

  • Phase 1 163 trials
  • Phase 1/2 76 trials
  • Phase 2 374 trials
  • Phase 2/3 57 trials
  • Phase 3 381 trials
  • Phase 4 111 trials
  • Not applicable 594 trials
  • Observational 379 trials
  • Expanded access 8 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 610 trials
  • Completed 1,174 trials
  • Terminated 320 trials
  • Other 39 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access)

Top of scale: 163

1998: 4 trials (Not applicable 1, Phase 3 1, Phase 2 2) 1999: 4 trials (Observational 1, Not applicable 2, Phase 3 1) 2000: 9 trials (Observational 4, Phase 3 2, Phase 2 3) 2001: 6 trials (Phase 4 1, Phase 3 4, Phase 2 1) 2002: 17 trials (Observational 2, Not applicable 2, Phase 4 3, Phase 3 3, Phase 2/3 1, Phase 2 4, Phase 1/2 2) 2003: 21 trials (Observational 3, Not applicable 3, Phase 4 1, Phase 3 2, Phase 2/3 2, Phase 2 8, Phase 1 2) 2004: 22 trials (Other 1, Observational 3, Not applicable 1, Phase 4 2, Phase 3 9, Phase 2 6) 2005: 26 trials (Observational 6, Not applicable 3, Phase 3 8, Phase 2 9) 2006: 42 trials (Other 1, Observational 7, Not applicable 6, Phase 4 6, Phase 3 8, Phase 2/3 2, Phase 2 7, Phase 1/2 2, Phase 1 3) 2007: 55 trials (Observational 9, Not applicable 10, Phase 4 3, Phase 3 15, Phase 2/3 1, Phase 2 9, Phase 1/2 1, Phase 1 7) 2008: 59 trials (Observational 14, Not applicable 15, Phase 4 4, Phase 3 11, Phase 2/3 2, Phase 2 13) 2009: 42 trials (Observational 10, Not applicable 10, Phase 4 2, Phase 3 9, Phase 2 7, Phase 1/2 1, Phase 1 3) 2010: 38 trials (Observational 7, Not applicable 12, Phase 3 9, Phase 2/3 1, Phase 2 4, Phase 1 5) 2011: 45 trials (Observational 12, Not applicable 7, Phase 4 3, Phase 3 8, Phase 2/3 2, Phase 2 10, Phase 1 3) 2012: 65 trials (Observational 9, Not applicable 19, Phase 4 3, Phase 3 18, Phase 2 11, Phase 1 5) 2013: 64 trials (Observational 10, Not applicable 15, Phase 4 6, Phase 3 12, Phase 2 16, Phase 1 5) 2014: 79 trials (Observational 15, Not applicable 25, Phase 4 3, Phase 3 9, Phase 2/3 1, Phase 2 12, Phase 1/2 6, Phase 1 8) 2015: 93 trials (Observational 15, Not applicable 25, Phase 4 5, Phase 3 17, Phase 2/3 2, Phase 2 15, Phase 1/2 6, Phase 1 8) 2016: 104 trials (Observational 13, Not applicable 31, Phase 4 6, Phase 3 15, Phase 2/3 1, Phase 2 17, Phase 1/2 10, Phase 1 11) 2017: 150 trials (Observational 23, Not applicable 48, Phase 4 9, Phase 3 20, Phase 2/3 1, Phase 2 30, Phase 1/2 9, Phase 1 10) 2018: 134 trials (Observational 22, Not applicable 29, Phase 4 11, Phase 3 38, Phase 2/3 4, Phase 2 19, Phase 1/2 3, Phase 1 8) 2019: 142 trials (Observational 33, Not applicable 44, Phase 4 5, Phase 3 24, Phase 2/3 4, Phase 2 19, Phase 1/2 4, Phase 1 9) 2020: 146 trials (Observational 33, Not applicable 38, Phase 4 3, Phase 3 24, Phase 2/3 4, Phase 2 27, Phase 1/2 3, Phase 1 14) 2021: 163 trials (Observational 28, Not applicable 54, Phase 4 7, Phase 3 22, Phase 2/3 7, Phase 2 24, Phase 1/2 11, Phase 1 10) 2022: 148 trials (Observational 26, Not applicable 46, Phase 4 11, Phase 3 17, Phase 2/3 7, Phase 2 24, Phase 1/2 7, Phase 1 10) 2023: 114 trials (Observational 23, Not applicable 24, Phase 4 5, Phase 3 23, Phase 2/3 4, Phase 2 22, Phase 1/2 5, Phase 1 8) 2024: 133 trials (Observational 22, Not applicable 45, Phase 4 5, Phase 3 22, Phase 2/3 5, Phase 2 19, Phase 1/2 4, Phase 1 11) 2025: 105 trials (Observational 13, Not applicable 43, Phase 4 4, Phase 3 15, Phase 2/3 2, Phase 2 18, Phase 1 10)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 96
2025 105
2024 133
2023 114
2022 148
2021 163
2020 146
2019 142
2018 134
2017 150

2026 is partial: trials registered with a 2026 start date so far, not a full year. 6 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Conditions studied

The specific conditions of the trials that list this site, most trials first.